Browsing by Subject "Intercalating agents"
Now showing items 1-1 of 1
-
Article
Mitoxantrone (novantrone*) as single agent and in combination chemotherapy in the treatment of advanced breast cancer
(1983)Nineteen out of 62 evaluable patients with advanced breast cancer achieved an objective tumour response to mitoxantrone (31%) given in a dose of 12-14 mg/m2 by i.v. infusion repeated at 3-weekly intervals. The response ...